OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Yuxiong Jiang, Youdong Chen, Qian Yu, et al.
BioDrugs (2023) Vol. 37, Iss. 1, pp. 35-55
Open Access | Times Cited: 53
Yuxiong Jiang, Youdong Chen, Qian Yu, et al.
BioDrugs (2023) Vol. 37, Iss. 1, pp. 35-55
Open Access | Times Cited: 53
Showing 26-50 of 53 citing articles:
IL-17A and TNF-α-induced Dectin-1 expression may promote keratinocyte proliferation in psoriatic lesions
Wenya Cui, Jiaying Liu, Shumin Kong, et al.
European Journal of Dermatology (2024) Vol. 34, Iss. 2, pp. 119-130
Open Access | Times Cited: 2
Wenya Cui, Jiaying Liu, Shumin Kong, et al.
European Journal of Dermatology (2024) Vol. 34, Iss. 2, pp. 119-130
Open Access | Times Cited: 2
Advanced Glycation End Products-Induced Activation of Keratinocytes: A Mechanism Underlying Cutaneous Immune Response in Psoriasis
Pan Kang, Jianru Chen, Shiyu Wang, et al.
Journal of Innate Immunity (2023) Vol. 15, Iss. 1, pp. 876-892
Open Access | Times Cited: 5
Pan Kang, Jianru Chen, Shiyu Wang, et al.
Journal of Innate Immunity (2023) Vol. 15, Iss. 1, pp. 876-892
Open Access | Times Cited: 5
Clinical advances in biological therapy for generalized pustular psoriasis: a review
Chang‐Yu Hsieh, Tsen‐Fang Tsai
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 37-50
Closed Access | Times Cited: 1
Chang‐Yu Hsieh, Tsen‐Fang Tsai
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 37-50
Closed Access | Times Cited: 1
“Two in one”: A novel DNA cascade amplification strategy for trace detection of dual targets
Qianqian Cai, Yuehui Wang, Yuanzhen Ning, et al.
Talanta (2024) Vol. 273, pp. 125978-125978
Closed Access | Times Cited: 1
Qianqian Cai, Yuehui Wang, Yuanzhen Ning, et al.
Talanta (2024) Vol. 273, pp. 125978-125978
Closed Access | Times Cited: 1
NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis
Fatma Z Kamel, Heba Allah Mohamed Hoseiny, Aya A El Shahawy, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Fatma Z Kamel, Heba Allah Mohamed Hoseiny, Aya A El Shahawy, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Real-life data of etanercept efficacy and safety in juvenile idiopathic arthritis: a 24-month retrospective study at a single center
Ramazan Emre Yiğit, Kadir Ulu, Şengül Çağlayan, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 855-862
Closed Access | Times Cited: 1
Ramazan Emre Yiğit, Kadir Ulu, Şengül Çağlayan, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 855-862
Closed Access | Times Cited: 1
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1378-1378
Open Access | Times Cited: 1
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1378-1378
Open Access | Times Cited: 1
Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis
Xiaojiao Li, Bing Li, De‐Ming Yang, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 1
Xiaojiao Li, Bing Li, De‐Ming Yang, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 1
Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: Real-World Data from a Care Center in Romania
Doriana-Sorina Lupea-Chilom, Caius Solovan, Simona Sorina Farcaş, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1015-1015
Open Access | Times Cited: 3
Doriana-Sorina Lupea-Chilom, Caius Solovan, Simona Sorina Farcaş, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1015-1015
Open Access | Times Cited: 3
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
Matteo Megna, Angelo Ruggiero, Antonia Salsano, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3503-3507
Open Access | Times Cited: 3
Matteo Megna, Angelo Ruggiero, Antonia Salsano, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3503-3507
Open Access | Times Cited: 3
Time-gated luminescent probes for lysosomal singlet oxygen: Synthesis, characterizations and bioimaging applications
Yundi Huang, Bo Song, Kaiwen Chen, et al.
Analytica Chimica Acta (2023) Vol. 1287, pp. 342063-342063
Closed Access | Times Cited: 2
Yundi Huang, Bo Song, Kaiwen Chen, et al.
Analytica Chimica Acta (2023) Vol. 1287, pp. 342063-342063
Closed Access | Times Cited: 2
Deciphering the Function of New Therapeutic Targets and Prospective Biomarkers in the Management of Psoriasis
Japneet Singh Purewal, Gaurav Doshi
Current Drug Targets (2023) Vol. 24, Iss. 16, pp. 1224-1238
Closed Access | Times Cited: 2
Japneet Singh Purewal, Gaurav Doshi
Current Drug Targets (2023) Vol. 24, Iss. 16, pp. 1224-1238
Closed Access | Times Cited: 2
Diosmetin ameliorates psoriasis-associated inflammation and keratinocyte hyperproliferation by modulation of PGC-1α / YAP signaling pathway
Dailin Yang, Mingwei Peng, Fengping Fu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112248-112248
Closed Access
Dailin Yang, Mingwei Peng, Fengping Fu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112248-112248
Closed Access
Itch improvement has a major and comparable effect on the Dermatology Life Quality Index in psoriasis and atopic dermatitis patients
Wolf‐Henning Boehncke, Adam Reich, Sonja Ständer, et al.
JEADV Clinical Practice (2024) Vol. 3, Iss. 5, pp. 1509-1517
Open Access
Wolf‐Henning Boehncke, Adam Reich, Sonja Ständer, et al.
JEADV Clinical Practice (2024) Vol. 3, Iss. 5, pp. 1509-1517
Open Access
Mapping the psoriasis research landscape: A comprehensive bibliometric analysis from 2012-2023
Sneha Garg, Muskan Chawla, Muskan Dixit, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access
Sneha Garg, Muskan Chawla, Muskan Dixit, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access
Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy
Dhanashree H. Surve, A J Fish, Maharshi Debnath, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Dhanashree H. Surve, A J Fish, Maharshi Debnath, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study
Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 12, pp. 3273-3290
Open Access
Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 12, pp. 3273-3290
Open Access
Immunomodulatory role of Trichinella spiralis–derived antigen on imiquimod-induced psoriasis in mice model
Nahla El Skhawy, Maha M. Eissa, Maram Allam, et al.
Parasitology Research (2024) Vol. 123, Iss. 11
Closed Access
Nahla El Skhawy, Maha M. Eissa, Maram Allam, et al.
Parasitology Research (2024) Vol. 123, Iss. 11
Closed Access
Aquaporin 3 inhibition Attenuates Imiquimod-Induced Psoriatic Symptoms in a Murine Model
Ryosuke Okubo, Manami Tanaka, Masato Yasui, et al.
Research Square (Research Square) (2024)
Open Access
Ryosuke Okubo, Manami Tanaka, Masato Yasui, et al.
Research Square (Research Square) (2024)
Open Access
Potential Effects of Some Factors on Psoriasis Course in Children
Svetlana G. Gubanova, Eduard T. Ambarchyan, Leyla S. Namazova-Baranova, et al.
Педиатрическая фармакология (2024) Vol. 21, Iss. 3, pp. 256-262
Open Access
Svetlana G. Gubanova, Eduard T. Ambarchyan, Leyla S. Namazova-Baranova, et al.
Педиатрическая фармакология (2024) Vol. 21, Iss. 3, pp. 256-262
Open Access
Development and Implementation of a Multidisciplinary Translational Course Using Rheumatoid Arthritis as a Model for Chronic Illness During the Medical Student Clerkship Year
Farzana Nuruzzaman, Wei-Hsin Lu, Karen DeChello, et al.
Medical Science Educator (2024)
Closed Access
Farzana Nuruzzaman, Wei-Hsin Lu, Karen DeChello, et al.
Medical Science Educator (2024)
Closed Access
Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO)
Saakshi Khattri, Álvaro González‐Cantero, Burhan Engın, et al.
Advances in Therapy (2024)
Open Access
Saakshi Khattri, Álvaro González‐Cantero, Burhan Engın, et al.
Advances in Therapy (2024)
Open Access
From Manifestations to Innovations: A Deep Dive into Psoriasis, its Clinical Diversity, Conventional Treatments, and Emerging Therapeutic Paradigms
Sneha Garg, Muskan Dixit, Iresha Malhotra, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113508-113508
Closed Access
Sneha Garg, Muskan Dixit, Iresha Malhotra, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113508-113508
Closed Access
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis
Francesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 1
Francesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 1
PREVALENCE OF PSYCHIATRIC COMORBIDITIES IN PATIENTS WITH PSORIASIS AND THEIR EVOLUTION UNDER TREATMENT
FLORENTINA MARCULESCU
FARMACIA (2023) Vol. 71, Iss. 1, pp. 185-193
Open Access
FLORENTINA MARCULESCU
FARMACIA (2023) Vol. 71, Iss. 1, pp. 185-193
Open Access
